SUTENT for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 52 adverse event reports in the FDA FAERS database where SUTENT was used for Neoplasm malignant.
Most Reported Side Effects for SUTENT
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Disease progression | 226 | 18.9% | 84 | 30 |
| Death | 225 | 18.8% | 225 | 37 |
| Diarrhoea | 164 | 13.7% | 23 | 40 |
| Fatigue | 140 | 11.7% | 12 | 23 |
| Nausea | 119 | 9.9% | 19 | 36 |
| Decreased appetite | 78 | 6.5% | 15 | 25 |
| Vomiting | 73 | 6.1% | 20 | 30 |
| Asthenia | 67 | 5.6% | 13 | 27 |
| Oral pain | 66 | 5.5% | 10 | 10 |
| Dysgeusia | 63 | 5.3% | 6 | 9 |
| Hypertension | 59 | 4.9% | 6 | 20 |
| Stomatitis | 58 | 4.8% | 8 | 12 |
| Pain in extremity | 53 | 4.4% | 9 | 9 |
| Renal cell carcinoma | 53 | 4.4% | 28 | 8 |
| Weight decreased | 51 | 4.3% | 3 | 12 |
Other Indications for SUTENT
Renal cancer (272)
Renal cell carcinoma (247)
Metastatic renal cell carcinoma (157)
Gastrointestinal stromal tumour (83)
Renal cancer metastatic (45)
Pancreatic neuroendocrine tumour (19)
Pancreatic carcinoma (12)
Clear cell renal cell carcinoma (10)
Malignant urinary tract neoplasm (9)
Thyroid cancer (8)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)